NMN vs NR: Which NAD+ Precursor Has the Better Evidence?

The one-sentence version

A direct human comparison exists, but it does not establish a longevity winner. A 2026 randomized, open-label study found similar increases in whole-blood NAD+ with NMN and NR over 14 days¹². Raising that biomarker is different from preventing disease or extending life.

What the direct comparison tested

Christen and colleagues analyzed 65 healthy adults across four groups: NR, NMN, nicotinamide and placebo. The NR and NMN groups received 1,000 mg daily. The study measured blood NAD+, not aging, disability or survival. Its short duration, small groups and researchers' industry employment limit what a shopper should infer¹².

Our reading: this supports a biochemical effect for both products. It does not prove that they are interchangeable for long-term health, or that a larger NAD+ increase would be better.

What they are

Both are precursors to NAD+, a coenzyme involved in energy metabolism and DNA repair. Oral NR and NMN participate in NAD+ metabolism; absorption and conversion are more complex than a capsule reaching every cell intact. Blood measurements cannot establish delivery to every tissue.

• •NR — nicotinamide riboside. One enzymatic step further from NAD+.
• •NMN — nicotinamide mononucleotide. One step closer in the pathway, which is part of the "more direct" marketing claim.

Being one step closer in a pathway does not establish a clinical advantage.

What NR trials contribute

NR has been studied in several healthy and disease populations:

• •Chronic supplementation was well tolerated and reliably elevated NAD+ in healthy middle-aged and older adults¹.
• •A randomized, double-blind, placebo-controlled trial of a commercial NR product examined safety and metabolism over eight weeks in healthy overweight adults².
• •A randomized placebo-controlled trial in obese men measured safety, insulin sensitivity and lipid-mobilizing effects³.
• •It has been taken into disease populations — a phase I trial in Parkinson's disease⁴ and a safety and tolerability study in heart failure with reduced ejection fraction⁵.

These studies provide tolerability information under their specific conditions. They do not establish the safety of taking a supplement for years.

What NMN trials contribute

NMN studies also report some population-specific findings:

• •NMN increased muscle insulin sensitivity in prediabetic women⁶ — a real, mechanistically coherent metabolic result.
• •It improved aerobic capacity in amateur runners⁷.
• •A 2023 trial examined its efficacy and safety in middle-aged adults⁸.

Both positive findings are in specific, narrow populations, and neither is an aging outcome.

Where both of them land

Both have raised measured NAD+ in human trials. That finding does not guarantee the same response to every commercial product.

Clinical results vary by population and endpoint. A 2025 review did not support using NMN or NR to preserve muscle mass and function in older adults overall⁹. However, the NICE trial in 90 people with peripheral artery disease reported a 17.6-meter improvement versus placebo in six-minute walking distance after six months of NR. It used a prespecified one-sided significance threshold of 0.10 and needs larger confirmation; this was not a trial of healthy aging¹⁰.

The broader verdict remains uncertain. A review published in 2026, with a search ending in October 2025, found biochemical activity but inconclusive clinical effectiveness for anti-aging or wellness¹¹. Its search period predates the direct comparison above.

So which should you buy?

Start with the outcome you want to change, rather than which molecule has the more persuasive pathway diagram.

• •For raising blood NAD+: both have human evidence. This is not an established treatment goal for healthy people.
• •For a diagnosed condition: a study in that condition deserves a clinician's interpretation; it is not a reason to replace established treatment.
• •For slowing aging or extending life: neither has demonstrated that benefit in humans in the evidence reviewed here.
• •For choosing a product: compare the actual ingredient, independent identity/purity testing, dose, cost and adverse-effect information. A study's dose describes its protocol, not a personal recommendation.

A prescription label does not make NAD+ tablets a better version of NR or NMN. Our RxSpan MD review discusses one such product, but evidence for these precursors cannot automatically be applied to a different formulation. Where each route has actually been tested is in NAD+ injections vs IV vs oral, and how these two sit against every other popular pill is in the best longevity supplements, rated by evidence.